Agents that enhance the immune response to foreign molecules, called adjuvants, will likely play a role in developing a successful COVID-19 vaccine, according to Terry D. Connell, PhD, professor of microbiology and immunology.
Nine faculty members and a staff member from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 17th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
Researchers exploring the nature of immunity after vaccination against Streptococcus pneumoniae have discovered that a specific type of white blood cell called neutrophils plays a more critical role than was previously known.
The PhD Program in Biomedical Sciences (PPBS) recognized 14 students from the Class of 2019-2020 — 11 doctoral students and three MD-PhD Program students — who completed their first year in the program and are moving on to their research laboratory match.
Twenty-seven doctoral, 58 master’s and 192 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May 17 virtual commencement ceremony.
Terry D. Connell, PhD, professor of microbiology and immunology, is leading research into the capacity of several bacterial molecules (LT-IIa, LT-IIb) to modulate immune responses to foreign antigens.
With COVID-19 tests and testing materials in short supply across the nation, researchers at the Jacobs School of Medicine and Biomedical Sciences have joined together to help compensate for the shortage.
Due to the COVID-19 global health pandemic, the Jacobs School of Medicine and Biomedical Sciences has transitioned to a distance learning model for student instruction to reduce density in the campus environment.
Fifteen students in the MD-PhD program at the Jacobs School of Medicine and Biomedical Sciences presented posters at the Tri-Institutional MD-PhD Research Day last fall at the Jacobs School building in downtown Buffalo.
Michael W. Russell, PhD, professor emeritus of microbiology and immunology, has been awarded the distinction of fellow by the American Association for the Advancement of Science (AAAS).
Eight faculty members from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 16th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
Garwood Medical Devices, LLC, has been granted “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the company’s BioPrax device, a tool it is developing to help eliminate biofilm infections on prosthetic knee implants.
